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ABSTRACT
Background The majority of women who undergo female 
genital mutilation/cutting (FGM/C) live in Africa. Although 
the UN Sustainable Development Goals call for intensified 
efforts to accelerate the abandonment of FGM/C, little is 
known about where in Africa the declines in prevalence 
have been fastest and whether changes in prevalence 
differ by women’s socioeconomic status.
Methods We use data from Demographic and Health 
Surveys and Multiple Indicator Cluster Surveys for 23 
African countries, collected between 2002 and 2016, and 
covering 293 170 women. We reconstruct long- term cohort 
trends in FGM/C prevalence spanning 35 years, for women 
born between 1965 and 1999. We compute absolute and 
relative changes in FGM/C prevalence and differentials 
in prevalence by women’s education and urban- rural 
residence. We examine whether socioeconomic differences 
in FGM/C are converging or diverging.
Findings FGM/C prevalence has declined fastest (in 
relative terms) in countries with lower initial prevalence, 
and more slowly in countries with higher initial prevalence. 
Although better- educated women and those living in urban 
areas tend to have lower prevalence, in some countries the 
opposite pattern is observed. Socioeconomic differentials 
in FGM/C have grown in the majority of countries, 
particularly in countries with moderate- to- higher overall 
prevalence.
Conclusions The documented relationship between 
absolute and relative FGM/C prevalence rates suggests 
that in settings with higher initial prevalence, FGM/C 
practice is likely to be more entrenched and to change 
more slowly. There is substantial variation between 
countries in socioeconomic differentials in prevalence and 
their changes over time. As countries change from higher 
to lower overall prevalence, socioeconomic inequalities in 
FGM/C are increasing.
INTRODUCTION
More than 200 million women and girls 
alive today are estimated to have undergone 
female genital mutilation/cutting (FGM/C), 
most of whom live in Africa.1 In 2015, the 
United Nations General Assembly agreed 
a series of Sustainable Development Goals 
(SDGs), including a specific target to elimi-
nate FGM/C by 2030.2 FGM/C is defined as 
‘all procedures involving partial or total removal of 
the external female genitalia or other injury to the 
female genital organs for non- medical reasons’ and 
is classified by severity into four categories.3 
Key questions
What is already known?
 ► Previous studies have documented trends in female 
genital mutilation/cutting (FGM/C) prevalence rates 
across African countries, but they are limited to anal-
yses of population- level changes in prevalence and 
absolute changes in prevalence rates.
 ► These studies identified that in the majority of 
African countries, FGM/C prevalence has been de-
creasing over time.
 ► There are currently no studies examining either rel-
ative changes in FGM/C prevalence to identify the 
countries in which prevalence has changed fastest, 
or disaggregating trends in FGM/C prevalence rates 
by women’s socioeconomic characteristics, across 
African countries.
What are the new findings?
 ► Our analyses include the estimation of historic, ab-
solute and relative changes in FGM/C prevalence 
rates as well as disaggregating trends by women’s 
education and urban- rural residence, for 23 African 
countries.
 ► We show that there is a relationship between abso-
lute and relative FGM/C prevalence rates and that 
comparisons of trends across countries are depen-
dent on the type of prevalence measure that is used.
 ► Our analyses suggests the presence of an underly-
ing FGM/C transition and uncovers growing socio-
economic inequalities in FGM/C as countries change 
from high to low prevalence.
What do the new findings imply?
 ► Progress in the abandonment of FGM/C has not been 
uniform across socioeconomic groups.
 ► Interventions towards the abandonment of FGM/C 
must be designed to acknowledge and accommo-
date the socioeconomic heterogeneity in prevalence 
that we document.
 ► This study enhances understanding of the dynam-
ics in FGM/C in Africa that is crucial for considering 
plausible future pathways and for developing theo-
ries of change in FGM/C prevalence.
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Despite sociocultural variations in FGM/C practices, it 
is widely recognised as a violation of human rights and 
harmful to the health of women and girls.4 The SDGs 
call for intensified national efforts to accelerate FGM/C 
elimination, but there is limited evidence to evaluate 
change across countries.5 Many studies have compared 
FGM/C prevalence in different African countries,6–14 but 
only a few studies have considered change in FGM/C 
prevalence rates over time.15–20 Little is known about 
the dynamics of change in FGM/C prevalence between 
and within African countries, in particular with respect 
to cohort dynamics (ie, changes over time in aggregate 
prevalence driven by behavioural change among younger 
generations).21 22
First, there is little evidence about the rate of change 
in practice of FGM/C, including research that iden-
tifies where declines in prevalence have been fastest. 
A few studies have compared long- run trends in adult 
prevalence rates for African countries where FGM/C is 
concentrated,17 19 20 but none of these have estimated 
both absolute and relative changes in prevalence.
Second, although cross- sectional studies have shown 
that FGM/C rates differ according to women’s socioeco-
nomic status,6–15 18 there is little cross- national evidence 
about whether socioeconomic differentials in FGM/C 
are changing (where socioeconomic differentials are 
defined as a comparison between members of a similar 
cohort group who have different social or economic char-
acteristics).22 Prevalence is declining for most types of 
FGM/C, including substitution of more severe with less 
severe types.17 For a limited number of countries, there 
is evidence that absolute declines in prevalence rates 
vary considerably by intracountry region, including the 
Central African Republic and Liberia.15 However, there 
is no systematic cross- country comparison of regional 
trends. Similarly, there is a lack of cross- national evidence 
to understand whether FGM/C prevalence is changing at 
different rates by socioeconomic factors.
These are important gaps in research. By analysing 
the dynamics of FGM/C prevalence, we can identify and 
begin to understand inequalities and—given evidence of 
declines—the extent to which subgroups are leading the 
transition towards low (or lower) prevalence. Accurate 
estimates of FGM/C dynamics are also vital if evidence- 
based policies are to be designed and evaluated,23–25 as 
well as in order to ensure the accuracy of projections 
of future FGM/C prevalence, including assessments of 
whether the SDG target is likely to be met.
This study compares and contrasts long- term trends 
in FGM/C prevalence across 23 African countries. It 
extends understanding by estimating absolute and rela-
tive long- term cohort trends in FGM/C prevalence—by 
education and urban- rural residence—using harmon-
ised data that are comparable across all 23 countries. We 
use a completed cohort approach based on estimation 
of nationally- representative prevalence rates for birth 
cohorts of adults who are no longer at risk of FGM/C, 
over 35 years. This approach offers more stable estimates 
of prevalence by excluding those who may be at future 
risk of FGM/C and greater insight into underlying socio-
economic dynamics of behaviours and experiences that 
are more comparable across cohorts. Prior compara-
tive studies of FGM/C prevalence trends using a cohort 
perspective15 17 19 20 neither consider relative change nor 
urban- rural or educational dynamics.
Our approach allows us to demonstrate how the 
dynamics of FGM/C in Africa are changing. We iden-
tify countries where FGM/C prevalence is static, rising 
or falling, as well as where it has been changing fastest 
in relative and absolute terms. By exploring the relation-
ship between absolute and relative changes in FGM/C 
prevalence rates, we link our empirical findings to 
theories that aim to explain FGM/C decline (or lack 
thereof), specifically the Theory of Social Convention.26 
By including the degree of socioeconomic heteroge-
neity in FGM/C dynamics, we additionally show which 
groups are leading the decline in FGM/C and provide 
much- needed evidence for evaluating future changes in 
FGM/C prevalence.
METHODS
Our methods include three stages: (1) data harmoni-
sation, (2) estimating trends in absolute and relative 
FGM/C prevalence for each country by birth cohort and 
(3) analysing educational and urban- rural differentials in 
these trends.
Data harmonisation
For each country, we either use data from the Demo-
graphic and Health Survey (DHS) or the Multiple Indi-
cator Cluster Survey (MICS) (table 1). We focus on coun-
tries that had at least one survey including an FGM/C 
module and where FGM/C practice is non- negligible 
(national prevalence of at least 5%). Three countries 
(Cameroon, Niger and Uganda) were excluded from 
the analysis due to a very small number of women under-
going FGM/C reflecting national prevalence of 1%–2%.
Both DHS and MICS are representative of national 
populations, have similar designs and are comparable. 
Our direct estimation of FGM/C prevalence relies on 
the quality of these data. We note that, although prior 
research has highlighted issues relating to data quality, 
such as the potential for some DHS survey questions to 
suffer from recall and reporting bias,27 or interviewer 
effects,28 prior research also suggests that these surveys 
are of sufficient quality for estimating FGM/C prevalence 
(as long as they avoid disaggregating by the type of prac-
tice, which is not something we do here).29 Moreover, 
the quality of these data are deemed sufficient in order 
to form the basis of indirect estimates of FGM/C preva-
lence among immigrants in high- income countries.30–36 
We harmonised all 23 national surveys to ensure that 
questions and response codes are similar, and that the 
data are of sufficient quality for analysis. We use the same 
approach for each country, thereby facilitating a direct 
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comparison within and between countries over time. 
During this harmonisation, we corresponded with DHS/
MICS support teams and completed quality assurance 
checks of our derived variables, including those for age 
and birth cohort, which are essential for the validity of 
our time series estimates. This quality assurance resulted 
in minimal changes to the data, and essentially involved 
renaming variables and recoding the values of variables 
(so that codes were consistent across surveys including 
for missing values). Our analyses account for the design 
of each survey using appropriate survey weights and the 
‘SVY’ command in Stata V.14.37
Estimating trends in absolute and relative FGM/C prevalence 
for each country and by birth cohort
We restrict our analysis to women aged 15–49 years in 
order to generate comparable time- series estimates 
of completed FGM/C prevalence rates. Of those who 
undergo FGM/C, in all countries in our study, almost all 
women did so before age 15. Those under 15 at the time 
of each survey are judged to be still at risk of FGM/C 
and are excluded from analysis. All the FGM/C modules 
include a question: “Have you yourself ever been circum-
cised?” which we use to calculate prevalence, that is, 
the percentage of women in a given cohort who report 
having undergone FGM/C. The potential limitation of 
such self- reported data is that women may be unwilling to 
disclose having undergone FGM/C due to the sensitivity 
of the subject or its illegality in some countries,15 or they 
may be unaware that they have been cut, especially if that 
happened at a young age.38 Despite these limitations, 
such self- reported data are the only source of information 
of FGM/C that can be used for comprehensive compar-
ative analyses. Table S1, online supplemental material 
shows that missing information about women’s FGM/C 
status is below 5% in all countries except for Chad (35%) 
and Kenya (53%). There are no substantial differences in 
the level if missing values by education level or place of 
residence in Chad and Kenya. We retain these two coun-
tries in our analysis, but the results should be interpreted 
while keeping in mind high levels of missing information 
on FGM/C status.
We reconstruct historic trends in prevalence using data 
on year of birth, grouped into 5- year birth cohorts, using 
one cross- sectional survey for each country. The range 
of cohorts that can be included depends on the date 
of each national survey. Since the majority of countries 
Table 1 Countries, data sources and sample sizes
Country abbr. Survey type Survey year Oldest cohort Youngest cohort Sample size
Benin BJ DHS 2011/12 1965–69 1995–97 16 152
Burkina Faso BF DHS 2010 1965–69 1990–94 15 430
Central African Republic CF MICS 2010 1965–69 1990–94 10 562
Chad TD DHS 2014/15 1965–69 1995–99 11 402
Côte d’Ivoire CI DHS 2011/12 1965–69 1995–97 9708
Djibouti DJ MICS 2006 1965–69 1990–91 5471
Egypt EG DHS 2014 1965–69 1995–99 21 441
Eritrea ER DHS 2002 1965–69 1985–87 6659
Ethiopia ET DHS 2005 1965–69 1985–89 11 367
Gambia GM DHS 2013 1965–69 1995–98 10 060
Ghana GH MICS 2011 1965–69 1995–96 9992
Guinea GN DHS 2012 1965–69 1995–97 8852
Guinea- Bissau GW MICS 2014 1965–69 1995–99 10 193
Kenya KE DHS 2014 1965–69 1995–99 14 682
Mali ML DHS 2012/13 1965–69 1995–97 10 259
Mauritania MR MICS 2015 1965–69 1995–99 13 612
Nigeria NG DHS 2013 1965–69 1995–98 35 983
Senegal SN DHS 2014 1965–69 1995–99 8453
Sierra Leone SL DHS 2013 1965–69 1995–98 16 371
Somalia SO MICS 2006 1965–69 1990–91 6241
Sudan SD MICS 2014 1965–69 1995–99 18 292
Tanzania TZ DHS 2015/16 1965–69 1995–99 12 619
Togo TG DHS 2013/14 1965–69 1995–99 9369
Total     293 170
DHS, Demographic and Health Survey; MICS, Multiple Indicator Cluster Survey.
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conducted their latest survey around 2010, we use surveys 
conducted just before or after 2010, even if a more recent 
survey is available. This is in order to generate trends that 
are comparable between countries. For most countries, 
we are able to estimate FGM/C prevalence for women 
born between 1965–69 and 1995–99. However, the upper 
end of this range is more restricted for some countries, 
most notably Burkina Faso, Central African Republic, 
Djibouti, Eritrea, Ethiopia and Somalia (table 1). We 
conduct additional analysis using 3- year, instead of 5- year, 
birth cohorts to make sure that our results are not sensi-
tive to alternative ways of grouping cohorts. We show 
these rates in the online supplemental material, table S2.
We then calculate an additional time series (for each 
country) that enables a cross- national comparison of 
relative change in FMG/C over time. This is done by 
indexing aggregate prevalence rates for each cohort to 
the national prevalence for women born 1965–69 and 
allows us to examine similarities and differences in the 
rate of change in FGM/C prevalence between countries.
Analysing educational and urban-rural differentials
Factors influencing the practice of FGM/C are dynamic, 
heterogeneous and context- specific.15 To explore the 
determinants of FGM/C, drivers of change and dynamics 
of inequality, we focus on several indicators of socioec-
onomic status. These are chosen from the indicators 
that were available and equivalent (ie, comparable) in 
all surveys. After examining all possible indicators, only 
two—education and place of residence—were sufficiently 
comparable to warrant inclusion. These two factors are 
known to be associated with FGM/C practices,6–14 18 
but are not the only factors. A third factor—household 
wealth—was identified for potential inclusion. However, 
it is well- known that wealth is more difficult to stand-
ardise and compare than other socioeconomic meas-
ures, in part because of its conceptual complexity.39–41 
It is for this reason that we analyse wealth, but restrict 
its presentation to the supplementary material due to 
concerns about validity and the fact that wealth index 
information is not available for all surveys (see online 
supplemental figure S1). We considered but were unable 
to calculate consistent and comparable trends by other 
factors including ethnicity and religion, in part due to 
the unavailability of questions for all countries, and in 
part due to the difficulty of cross- national harmonisation 
of these variables (and their categories).
We calculate the difference in absolute prevalence 
for: (a) women who have no education vs those who 
have some education and (b) women who live in rural 
areas versus those who live in urban areas. Having some 
education is defined as having completed any years of 
schooling. We use the classification of urban- rural areas 
as defined in a given survey for each country, which is 
based on each country’s urban- rural definition at the time 
of the survey,42 and is one of the most common ways of 
operationalising this concept for the analysis of socioeco-
nomic dynamics and development.22 43 Both education 
and residence variables are recorded at the time of the 
survey, and do not capture an individual’s characteristics 
at the time of FGM/C. While this fact has no implications 
for the analysis of educational differences, it is a poten-
tial limitation for the study of urban- rural differences 
because migration between rural and urban areas may 
differ by FGM/C status. We are not aware of evidence 
that indicates whether this is the case, but we acknowl-
edge this limitation and later discuss its possible influ-
ence on our results. The socioeconomic composition of 
the population (the per cent of women with some educa-
tion and living in urban areas) is presented in online 
supplemental material, table S3.
Patient and public involvement
This research was carried out without any public involve-
ment, essentially because it was not feasible to involve 
members of the public given the time and funding that 
were available.
RESULTS
In general, there has been a decline in the prevalence 
of FGM/C, however there is stark variation across coun-
tries in long- run trends (figure 1). For women born in 
1965–69, prevalence varies from 5% in Ghana (the lowest 
in our study) to 99% in Guinea (the highest). In some 
countries, such as Somalia and Mali, there has been no 
decline in prevalence, and in Gambia there appears to 
have been a small increase. In Sierra Leone, the rate has 
fallen by 27% for women born 30 years later, reflected in 
a change in the indexed FGM/C prevalence from 1 to 
0·73 between 1965–69 and 1995–99. There is no obvious 
pattern by region, for example, the neighbouring coun-
tries of Gambia, Senegal and Mauritania all exhibit 
very different trends. Gambia is the only country in 
our study where FGM/C prevalence increased over the 
30- year period; prevalence fell steadily in Mauritania by 
around 2%–3% per year, whereas prevalence in Senegal 
increased for cohorts born 1970–89, but declined rapidly 
thereafter.
Alongside Sierra Leone, several other countries in the 
top two quartiles of prevalence (top two rows of figure 1) 
exhibit material declines in prevalence of >10%: Sudan 
(11%), Eritrea (15%), Ethiopia (21%) and Burkina 
Faso (30%). Nonetheless, the pace of decline in these 
countries is generally slower as compared with coun-
tries of below average prevalence (bottom two rows of 
figure 1). Most of these lower prevalence countries have 
seen a reduction of >30% in FGM/C prevalence across 
three decades, with the exception of Chad, Senegal and 
Guinea- Bissau (reductions of 20%, 16% and 8%, respec-
tively). Different countries show the ‘largest’ reduction, 
depending on whether the reduction is calculated in 
absolute or relative terms. When comparing those born 
1965–69 with the most recent cohorts, the largest abso-
lute declines are for Kenya (28 percentage points), 
Burkina Faso (27), Sierra Leone (27), Nigeria (23) and 
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Ethiopia (18) (absolute FGM/C prevalence rates for the 
total population are shown in online supplemental table 
S4). These are countries with substantial relative declines 
as well (71%, 30%, 27%, 60% and 21%, respectively). 
Nonetheless, the largest relative declines over the same 
period occurred in Tanzania, Benin, Togo and Ghana 
(declines of 74%, 88%, 83% and 78%, respectively).
Another pattern that emerges from our analysis of 
long- term trends is the relationship between ‘initial’ 
absolute FGM/C prevalence, for those born 1965–69 
(index=100), and the relative change in prevalence for 
subsequent cohorts (R2=0·63). Countries with the highest 
prevalence for those born in 1965–69 also exhibit a much 
smaller relative change in prevalence for cohorts born 
over the next three decades (figure 2). The largest rela-
tive declines are for countries where FGM/C was already 
a minority practice for the 1965–69 birth cohort.
There is considerable cross- national variation in the 
magnitude of educational and urban- rural differences 
in FGM/C prevalence. Figures 3 and 4 show absolute 
FGM/C prevalence rates by socioeconomic character-
istics; countries are ranked by the aggregate FGM/C 
prevalence rate of the 1965-69 cohorts (relative FGM/C 
prevalence rates by education level and place of resi-
dence are shown in the online supplemental table S4). 
For women born 1965–69, those with no education have 
a much higher prevalence in Guinea- Bissau, Gambia, 
Côte d’Ivoire and Kenya (differentials of >15 percentage 
points as compared with those who have any educa-
tion) (figure 3). In some countries (eg, Sudan, Nigeria), 
women with some education from these cohorts have 
Figure 1 Indexed time series of trends in female genital mutilation/cutting (FGM/C) prevalence by birth cohort (relative change 
in FGM/C prevalence). Countries are sorted according to the national FGM/C prevalence rate for 1965-69 (oldest) cohort, which 
is shown in the parentheses.
Figure 2 Relationship between initial female genital 
mutilation/cutting (FGM/C) prevalence (1965–69 cohort) 
and the rate of change. Note: the percentage change is the 
change in FGM/C prevalence rates between those born 
1965–69 (oldest cohort) and the youngest cohort available 
for each country.
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a higher prevalence than women with no education, 
and the difference is >10 percentage points. This shows 
that education is not a good predictor of FGM/C cross- 
nationally, although it is notable that educational differ-
entials among women born in 1965–69 are largest in 
countries with moderate levels of overall prevalence, and 
smallest in countries with the highest prevalence.
The heterogeneity that is evident for women born in 
1965–69 is amplified when examining how differentials 
have changed over time. The trends in differentials move 
in different directions across countries, including in diver-
gent ways for educational differentials, and there is also 
sizeable variation in the changing magnitude of differ-
entials. For example, in Central African Republic, the 
difference in prevalence between women with no educa-
tion and some education increases from 4 percentage 
points for the 1965–69 cohort to 17 percentage points for 
the 1990–94 cohort. By contrast, in Côte d’Ivoire where 
there is also a sizeable differential by education, it is much 
more stable over time. In Ghana, the same educational 
differential changes in the opposite direction, decreasing 
from 11 to 2 percentage points.
These socioeconomic differentials can be interpreted 
as a measure of inequality in FGM/C practices. To this 
extent, countries can be categorised as becoming more 
or less equal if differentials become smaller or larger (in 
absolute terms). Countries trending towards equality 
include Gambia, Nigeria, Benin, Togo and Ghana. 
However, these countries appear to be in the minority as 
compared with those where inequality is widening, such 
as Sierra Leone, Burkina Faso, Eritrea, Ethiopia, Guinea- 
Bissau, Kenya or Central African Republic. Increases in 
educational differentials occurred in countries that had 
moderate- to- high levels of initial overall prevalence (ie, 
among the 1965–69 cohort). Consequently, for more 
recent cohorts, educational differentials are largest in 
countries with moderate- to- high prevalence. It is only 
among countries with the lowest initial prevalence 
rates—such as Benin, Togo and Ghana—that educational 
differentials have consistently reduced.
The variation in magnitude (and direction) of urban- 
rural differentials is less pronounced than for education 
(figure 4). In the majority of countries, women who 
lived in urban areas at the time of the survey have lower 
FGM/C prevalence than rural women, although in many 
cases the difference is small or negligible. For the oldest 
cohort, there is a much lower urban prevalence (>10 
percentage points) in Guinea- Bissau, Mauritania and 
Tanzania. However, the opposite is true in Nigeria, Chad, 
Sudan, Côte d’Ivoire and Eritrea, where urban preva-
lence rates are higher (with differentials ranging from 2 
to 18 percentage points). As with education, urban- rural 
Figure 3 Absolute FGM/C prevalence rates by education level, percentage point (pp) difference (diff.) in female genital 
mutilation/cutting (FGM/C) prevalence between women with no education and some education (diff. (pp)), oldest and youngest 
cohorts. Note: countries are ranked according to the national FGM/C prevalence rates of the 1965–69 cohorts (oldest cohort). 
The youngest cohorts are listed in table 1.
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differentials tend to be largest in countries with moderate 
levels of overall prevalence. For the latest cohorts, differ-
entials remain largest in countries with moderate prev-
alence, and show an increase in countries with higher 
overall levels of prevalence (Sierra Leone, Egypt, Eritrea, 
Sudan and Burkina Faso). In drawing these conclusions, 
it is important to note that place of residence is recorded 
at the time of interview, such that urban- rural differen-
tials also reflect patterns of (rural to urban) migration 
over time. Nevertheless, we frequently observe that differ-
entials between rural and urban areas are increasing.
DISCUSSION
While FGM/C practices vary substantially across and 
within countries, a comparison of national trends can 
illuminate where, to what extent, and how rapidly change 
is occurring. Our results focus on the dynamics and 
heterogeneity of FGM/C within and between countries, 
and show the extent to which the practice is changing 
across Africa.
The analysis of relative changes in prevalence rates 
provides a novel perspective for looking at the evolu-
tion of FGM/C practices and allows us to identify where 
it has been changing fastest. Despite considerable vari-
ation across countries, we uncover a clear relationship 
between absolute rates and relative changes in FGM/C 
prevalence. Relative declines in cohort- specific preva-
lence rates have been faster in countries that began with 
low absolute levels of prevalence. These findings provide 
macro- level evidence in support of the Theory of Social 
Convention, as applied to FGM/C.26 In countries with 
lower initial prevalence rates, the mechanisms of social 
convention—such as marriageability or peer conventions 
that support the practice of FGM/C—are less prevalent 
and less likely to be reinforced because a minority of the 
population practices FGM/C.44 In settings with higher 
initial prevalence, these social conventions are more 
likely to be entrenched and less likely to change.
These macro- level patterns are not deterministic: 
high prevalence does not mean that high prevalence 
will persist. With the exception of a few countries such 
as Somalia, Mali and Gambia, even in the highest prev-
alence countries FGM/C prevalence has started to 
decline, although at a slow pace. However, we also docu-
ment that, as in the cases of Senegal and Guinea- Bissau, 
prevalence is not necessarily decreasing monotonically: 
initial declines in prevalence do not always lead to subse-
quent declines.
We show substantial variation between countries in 
their socioeconomic differentials in FGM/C prevalence. 
Figure 4 Absolute female genital mutilation/cutting (FGM/C) prevalence rates by place of residence, percentage point (pp) 
difference (diff.) in FGM/C prevalence between women in rural areas and urban areas (diff. (pp)), oldest and youngest cohorts. 
Note: countries are ranked according to the national FGM/C prevalence rates of the 1965–69 cohorts (oldest cohort). The 
youngest cohorts are listed in table 1.
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Theories of diffusion suggest that certain socioeconomic 
groups—such as those with higher education—are more 
likely to adopt new (non- traditional) behaviours.45 Yet, 
we show that FGM/C differentials are not in the same 
direction across countries, and women with some educa-
tion (or living in urban areas) can have higher average 
prevalence rates. As noted elsewhere, it is important to 
realise that different communities practice FGM/C in 
different social contexts, and that each context presents 
specific challenges for reformers.46 Interventions towards 
abandonment of FGM/C must be designed to acknowl-
edge and accommodate the heterogeneity we document, 
not least with respect to generalisability.
Finally, we show how cross- national variation in socio-
economic differentials change over time. In the past, 
differentials were smallest in countries where the majority 
of the population practice FGM/C, and were largest in 
countries with moderate prevalence levels. However, 
socioeconomic inequalities in FGM/C have decreased in 
the lowest prevalence countries and increased in coun-
tries with moderate- to- high levels of prevalence. We spec-
ulate that these changes are, at least in part, driven by an 
underlying FGM/C transition, as countries change from 
high to low prevalence—or from FGM/C being a majority 
to a minority practice. Once a minority of the popula-
tion practices FGM/C, then it appears that socioeco-
nomic differences in the practice (begin to) disappear, 
at least at the national- level. As well as adding knowledge 
about the dynamics of change in FGM/C, these findings 
can inform research to develop and enhance theories 
of change, as well as in order to project future levels of 
FGM/C prevalence.
We recommend that future research seeks to develop 
an even richer understanding of socioeconomic trends 
in FGM/C—and the complex behaviour that deter-
mines these trends—using both qualitative and qualita-
tive methods. Nevertheless, we hope that our evidence 
will help to enable programme directors, policy- makers, 
researchers and members of civil society to better under-
stand changes in FGM/C that are crucial for considering 
plausible future policies.
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Table S1: Per cent missing values for information about women’s FGM/C status, by country, for total 






education no education urban rural 
Benin 0.0 0.0 0.0 0.0 0.0 
Burkina Faso 0.1 0.0 0.1 0.0 0.1 
Central African Republic 0.2 0.3 0.2 0.3 0.2 
Chad 35.1 34.6 35.4 36.5 34.7 
Cote d'Ivoire 0.1 0.1 0.1 0.1 0.1 
Djibouti 0.3 0.1 0.4 0.3 0.4 
Egypt 0.0 0.0 0.0 0.1 0.0 
Eritrea 0.0 0.1 0.0 0.1 0.0 
Ethiopia 3.1 3.9 2.5 5.1 2.2 
Gambia 0.3 0.3 0.2 0.3 0.2 
Ghana 0.0 0.0 0.0 0.0 0.0 
Guinea 0.1 0.1 0.1 0.2 0.0 
Guinea-Bissau 0.0 0.0 0.0 0.0 0.0 
Kenya 52.6 52.6 52.7 52.9 52.4 
Mali 0.0 0.0 0.0 0.0 0.0 
Mauritania 1.1 1.3 0.7 1.2 1.1 
Nigeria 4.5 3.4 6.5 4.9 4.2 
Senegal 0.0 0.0 0.0 0.0 0.0 
Sierra Leone 0.1 0.1 0.1 0.1 0.1 
Somalia 0.1 0.2 0.1 0.3 0.1 
Sudan 0.1 0.1 0.1 0.0 0.1 
Tanzania 0.0 0.0 0.0 0.0 0.0 















BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance
Supplemental material placed on this supplemental material which has been supplied by the author(s) BMJ Global Health
 doi: 10.1136/bmjgh-2020-003088:e003088. 5 2020;BMJ Global Health, et al. Batyra E
 
 
Table S2: FGM/C prevalence by 3-year cohorts, total population (T), by education level (SE, NE) and place of residence (U, R), absolute 






cohort (Y) T-O-A T-Y-A T-Y-R SE-O-A SE-Y-A SE-Y-R NE-O-A NE-Y-A NE-Y-R U-O-A U-Y-A U-Y-R R-O-A R-Y-A R-Y-R 
Guinea 1965-67 1995-97 1.00 0.94 0.94 0.98 0.92 0.93 1.00 0.97 0.97 0.98 0.95 0.96 1.00 0.93 0.93 
Somalia 1965-67 1989-91 0.98 0.97 0.99 0.98 0.95 0.97 0.98 0.98 1.01 0.96 0.96 0.99 0.99 0.97 0.98 
Sierra Leone 1965-67 1995-97 0.98 0.74 0.75 0.91 0.71 0.78 0.99 0.84 0.85 0.93 0.63 0.68 0.99 0.81 0.82 
Egypt 1965-67 1995-97 0.95 0.89 0.93 0.93 0.90 0.97 0.98 0.80 0.82 0.91 0.79 0.87 0.99 0.91 0.93 
Sudan 1965-67 1995-97 0.94 0.82 0.88 0.98 0.85 0.87 0.89 0.66 0.74 0.95 0.77 0.81 0.93 0.85 0.92 
Eritrea 1965-67 1983-85 0.93 0.79 0.84 0.91 0.77 0.84 0.95 0.86 0.90 0.92 0.74 0.80 0.94 0.82 0.87 
Djibouti 1965-67 1989-91 0.93 0.89 0.95 0.95 0.88 0.92 0.92 0.91 0.99 0.93 0.89 0.96 0.96 0.90 0.94 
Mali 1965-67 1995-97 0.92 0.90 0.98 0.91 0.89 0.98 0.92 0.91 0.99 0.90 0.90 0.99 0.92 0.90 0.98 
Burkina Faso 1965-67 1992-94 0.88 0.58 0.66 0.82 0.47 0.57 0.89 0.67 0.76 0.87 0.52 0.60 0.88 0.61 0.69 
Ethiopia 1965-67 1986-88 0.83 0.65 0.78 0.87 0.62 0.71 0.83 0.70 0.84 0.87 0.61 0.70 0.83 0.67 0.81 
Gambia 1965-67 1995-97 0.74 0.77 1.05 0.52 0.78 1.51 0.80 0.74 0.92 0.68 0.74 1.08 0.79 0.81 1.02 
Mauritania 1965-67 1995-97 0.74 0.64 0.86 0.68 0.62 0.92 0.80 0.70 0.87 0.60 0.49 0.82 0.87 0.78 0.90 
Cote d'Ivoire 1965-67 1995-97 0.46 0.29 0.64 0.37 0.18 0.49 0.50 0.46 0.92 0.52 0.30 0.58 0.40 0.28 0.70 
Guinea-Bissau 1965-67 1995-97 0.42 0.43 1.01 0.28 0.36 1.29 0.49 0.80 1.63 0.33 0.37 1.14 0.50 0.50 1.00 
Kenya 1965-67 1995-97 0.40 0.12 0.29 0.38 0.10 0.25 0.49 0.89 1.81 0.31 0.09 0.30 0.43 0.13 0.29 
Nigeria 1965-67 1995-97 0.37 0.16 0.42 0.48 0.17 0.35 0.26 0.12 0.47 0.48 0.17 0.35 0.30 0.14 0.49 
Chad 1965-67 1995-97 0.35 0.33 0.94 0.28 0.25 0.90 0.37 0.43 1.14 0.36 0.32 0.89 0.35 0.34 0.96 
C.A. Republic 1965-67 1992-94 0.33 0.18 0.54 0.31 0.13 0.41 0.35 0.29 0.82 0.26 0.10 0.40 0.37 0.23 0.61 
Senegal 1965-67 1995-97 0.24 0.21 0.88 0.20 0.22 1.11 0.26 0.19 0.73 0.23 0.18 0.80 0.27 0.25 0.92 
Tanzania 1965-67 1995-97 0.19 0.05 0.29 0.14 0.04 0.31 0.34 0.17 0.51 0.05 0.02 0.33 0.24 0.08 0.32 
Benin 1965-67 1995-97 0.12 0.01 0.10 0.05 0.01 0.14 0.15 0.03 0.19 0.09 0.01 0.06 0.14 0.02 0.13 
Togo 1965-67 1995-97 0.10 0.02 0.21 0.06 0.02 0.31 0.13 0.05 0.34 0.10 0.02 0.20 0.09 0.02 0.22 
Ghana 1965-67 1992-94 0.05 0.02 0.37 0.02 0.01 0.63 0.12 0.12 1.04 0.02 0.01 0.59 0.08 0.02 0.28 
Note: O-oldest cohort, Y-youngest cohort, T-total population, SE-some education, NE-no education, U-urban, R-rural, A-absolute rate, R-relative rate. Countries 
are ranked according to the national FGM/C prevalence rates of the 1965-67 cohorts.  Relative rates for the oldest cohort are equal to 1. 
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Figure S1: Absolute FGM/C prevalence rates by household wealth quantile, percentage point (pp) 
difference (Diff.) in female genital mutilation/cutting (FGM/C) prevalence between women living in 
the richest and richer households (top 40% - Rich) and women living in the poorest and poorer 




















Note: Countries are ranked according to the national FGM/C prevalence rates of the 1965-69 cohorts (oldest cohort). The 
youngest cohorts as listed in table 1. Wealth index is expressed in terms of quintiles that divide households according to wealth: 
(1) poorest, (2) poorer, (3) middle, (4) richer and (5) richest. Wealth index is not available for Djibouti 2006 MICS and this 
country is omitted from the figure. 
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Table S3: Per cent of women with some education and living in urban areas, oldest and youngest 
cohorts (%) 
 % Some Education % Urban 
Country /Cohort Oldest Youngest Oldest Youngest 
Benin 28.8 73.9 45.5 49.1 
Burkina Faso 13.5 48.5 22.5 25.2 
Central African Republic 54.6 65.3 39.1 40.7 
Chad 20.8 55.2 20.3 26.4 
Cote d'Ivoire 36.3 60.7 45.6 59.3 
Djibouti 29.2 77.2 96.8 97.5 
Egypt 55.9 90.6 42.4 17.7 
Eritrea 34.9 84.1 43.4 47.0 
Ethiopia 19.6 54.4 14.0 21.3 
Gambia 23.8 76.0 51.7 52.6 
Ghana 69.4 97.2 55.8 48.6 
Guinea 14.3 60.0 27.8 40.3 
Guinea-Bissau 32.8 85.3 45.0 53.1 
Kenya 87.7 97.6 29.8 30.3 
Mali 13.7 48.9 19.1 31.9 
Mauritania 60.1 86.4 49.7 49.0 
Nigeria 52.8 71.7 41.9 41.5 
Senegal 31.2 69.9 54.8 50.0 
Sierra Leone 20.1 81.7 30.4 40.3 
Somalia 31.2 57.0 32.2 45.3 
Sudan 46.9 85.9 34.9 32.5 
Tanzania 81.4 93.5 28.7 37.9 
Togo 47.6 89.4 35.1 44.5 
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Table S4: FGM/C prevalence for total population for the oldest and youngest cohorts (absolute rates) and FGM/C prevalence for the 




oldest cohort  
(absolute rate) 
total population, 





no education, youngest 







Guinea 0.99 0.94 0.94 0.97 0.97 0.93 
Somalia 0.99 0.98 0.98 1.01 1.00 0.99 
Sierra Leone 0.98 0.71 0.74 0.83 0.64 0.79 
Egypt 0.95 0.88 0.96 0.81 0.86 0.91 
Djibouti 0.93 0.88 0.92 0.99 0.94 0.95 
Eritrea 0.93 0.79 0.83 1.00 0.77 0.91 
Sudan 0.92 0.82 0.86 0.75 0.80 0.93 
Mali 0.92 0.90 0.99 0.98 1.00 0.98 
Burkina Faso 0.89 0.62 0.61 0.78 0.63 0.74 
Ethiopia 0.84 0.66 0.70 0.87 0.74 0.80 
Gambia 0.75 0.77 1.37 0.93 1.06 1.00 
Mauritania 0.73 0.64 0.92 0.93 0.82 0.93 
Guinea-Bissau 0.46 0.42 1.25 1.49 0.98 0.93 
Cote d'Ivoire 0.45 0.29 0.59 0.86 0.64 0.64 
Chad 0.40 0.32 0.75 0.96 0.70 0.83 
Kenya 0.40 0.12 0.26 1.53 0.27 0.30 
Nigeria 0.38 0.15 0.34 0.48 0.36 0.46 
C.A. Republic 0.31 0.20 0.48 0.92 0.43 0.75 
Senegal 0.25 0.21 1.03 0.69 0.75 0.90 
Tanzania 0.20 0.05 0.25 0.53 0.24 0.28 
Benin 0.11 0.01 0.11 0.23 0.07 0.15 
Togo 0.10 0.02 0.26 0.30 0.16 0.18 
Ghana 0.05 0.01 0.53 0.25 0.09 0.26 
Note: Countries are ranked according to the national FGM/C prevalence rates of the 1965-69 cohorts. The oldest and youngest cohorts as listed in table 1. 
Relative rates by education level and place of residence for the oldest cohort are equal to 1. 
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